Quest Partners LLC Enanta Pharmaceuticals Inc Transaction History
Quest Partners LLC
- $1.12 Trillion
- Q3 2024
A detailed history of Quest Partners LLC transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Quest Partners LLC holds 19,123 shares of ENTA stock, worth $173,636. This represents 0.02% of its overall portfolio holdings.
Number of Shares
19,123
Previous 11,588
65.02%
Holding current value
$173,636
Previous $150 Million
31.82%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding ENTA
# of Institutions
110Shares Held
21.1MCall Options Held
4.8KPut Options Held
4.6K-
Farallon Capital Management LLC San Francisco, CA2.11MShares$19.1 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.98MShares$18 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.85MShares$16.8 Million0.0% of portfolio
-
Krensavage Asset Management, LLC New York, NY1.5MShares$13.6 Million8.7% of portfolio
-
Morgan Stanley New York, NY1.1MShares$10 Million0.0% of portfolio
About ENANTA PHARMACEUTICALS INC
- Ticker ENTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,724,900
- Market Cap $188M
- Description
- Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...